Linear IgA Bullous Dermatosis (LABD) Triggered by a Vaccine
Linear IgA Bullous Dermatosis and Vaccine ReactionsLinear IgA Bullous Dermatosis (LABD) is an autoimmune disease that affects the skin. The main symptoms are painful blisters and rashes. The disease is also sometimes called “chronic bullous” or “linear IgA dermatosis.” The skin disease is not hereditary and it is also not contagious.
Doctors are not sure what causes LABD, but medical reports show that IgA can emerge within 2 to 14 days after receiving certain vaccinations.Patients who have developed LABD after a vaccine may be eligible for compensation from the federal government.
What to do if you Developed Linear IgA Bullous Dermatosis After a VaccineFirst, always get medical attention as soon as possible. Then contact a vaccine injury lawyer, like the ones at MCT Law, who can effectively represent you in the Federal Vaccine Court. If your Linear IgA Bullous Dermatosis (LABD) was triggered by a vaccine, you may be eligible for compensation. Filing a vaccine injury claim is very complicated. But you can hire an attorney to help you get through the process. The good news is that you never have to pay legal fees when a vaccine injury lawyer represents you in the Vaccine Injury Compensation program. When your case is finished, our Law Firm works with the court to get legal fees and reimbursements paid. None of these costs are ever your financial responsibility. You never have to share ANY portion of your money for damages with our law firm.
What Vaccines Have Been Linked to Linear IgA Dermatosis
Vaccines normally protect us by activating the immune system, however, sometimes – and it is not clear why this happens – the immune system may become overactivated by a vaccine. Therefore leading to autoimmune diseases like LABD.
Here, we summarize some of the research that links vaccines to LABD:
Influenza (flu) Vaccine
One study reports the case of a 54-year-old woman who developed LABD symptoms within a few days of receiving a flu vaccine. The doctors concluded that “given the temporal association between the influenza vaccination and onset of the eruption, we feel the immunization was the likely trigger” (Alberta-Wszolek et. al, 2009)
Human Papillomavirus Vaccine
One report identified a case where the patient developed LABD after receiving the HPV vaccine (Ikeya et. al, 2012). This is consistent with other studies that have shown the HPV vaccine can trigger other autoimmune diseases.
DTaP, Polio, Hep B, and Flu Vaccines
One study records the case of a 3 month-old boy who developed severe LABD symptoms just two days after receiving a vaccination (Baroero et. al, 2017).The authors concluded that the short timespan between the vaccine and the disease onset suggests an association between the vaccine and the disease.
The same study found that a 17 month-old girl developed LABD symptoms 7 days after receiving the same vaccine. Again, the doctors concluded that the vaccine may have triggered the disease (Baroero et. al, 2017).
What are the Symptoms of Linear IgA Bullous Dermatosis?
In general, the main symptoms of LABD are blisters and rashes on or beneath the skin. Additionally, leading up to appearance of blisters, patients with LABD usually experience burning and/or itching of the skin. However, the symptoms of LABD vary depending on the person’s age, and what areas of the body are affected by LABD.
If you or a loved one experience any of the following symptoms after receiving a vaccine, you should seek medical attention immediately. A vaccine may be the cause.
How is Linear IgA Bullous Dermatosis Treated?
If you have linear IgA dermatosis, you should also consult a dermatologist and seek treatment as soon as possible. There are a variety of treatment options for patients suffering from LABD, such as antibacterial ointments, steroids and intravenous immunoglobulin.
Some cases of LABD resolve within 48 hours of treatment, but some cases of LABD linger for weeks, and have the ability to cause serious complications. For this reason, it is important to seek treatment as soon as possible.